Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: physiocochemical similarity of MAF to gamma interferon (IFN-gamma). 1984

Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki

During the course of an investigation designed to separate macrophage activating factor (MAF) activity from interferon (IFN) antiviral activity in the lymphokine-rich fraction (LKF) produced by stimulation of murine splenic cells with concanavalin A (Con A), we found molecular evidence for the similarity of the two activities. MAF activity was expressed as the rate of inhibition of intracellular growth of Salmonella typhimurium in macrophages based on the linear correlation between relative MAF activity and LKF concentration. The antiviral substance in LKF was identified as IFN-gamma based on the observation that its activity was inactivated at pH 2 and neutralized with anti-mouse IFN-gamma serum but not with anti-mouse IFN-alpha/beta serum. MAF and IFN antiviral activities displayed identical sensitivity to pH 2 and temperature. Further, neither activity was affected by beta-mercaptoethanol, but both were inactivated by guanidine hydrochloride and by sodium dodecyl sulfate, suggesting that the structures related to conformation of the protein of the two molecules may be similar. In affinity chromatography of the LKF on a Con A-Sepharose column, MAF and IFN activities were found in both the nonadsorbing (F I) and adsorbing (F II) fractions. However, the rates of F II of MAF and IFN activities increased proportionally when the sample was applied on a column of higher capacity, suggesting that the molecular structure of the mannose-containing glycosyl moiety of the two molecules may also be similar. Moreover, the intact or modified form of MAF and IFN activities of different LKF preparations showed a strong correlation, indicating that the production and denaturation of MAF activity were proportional to those of IFN antiviral activity. The results of this study provide strong evidence that MAF and IFN antiviral activities may reside in virtually the same molecular species.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
January 1988, Advances in experimental medicine and biology,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
March 1984, The Journal of experimental medicine,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
January 1988, Advances in experimental medicine and biology,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
January 1983, Nature,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
May 1988, Cellular immunology,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
January 1982, Journal of interferon research,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
February 1985, The Japanese journal of experimental medicine,
Y Fukazawa, and K Kagaya, and H Miura, and T Shinoda, and K Natori, and S Yamazaki
January 1984, Contemporary topics in immunobiology,
Copied contents to your clipboard!